Hypothalamic-Pituitary-Adrenal Axis in Gastrointestinal Physiology

Physiology of the Gastrointestinal Tract

Volumn 1, Issue , 2012, Pages 791-816

  Fukudo, Shin ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882503933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382026-6.00028-2     Document Type: Chapter

References (136)

1. Iversen S, Iversen L, Saper CB The autonomic nervous system and the hypothalamus. Principles of Neural Science 2000, 960-980. McGraw-Hill, New York. 4th ed. E.R. Kandel, J.H. Schwartz, T.M. Jessel (Eds.).
2. Cannon WB: Bodily Changes in Pain, Hunger, Fear, and Rage. 2nd ed., Boston, MA, Branford, 1953.
3. Fukudo S, Kanazawa M, Kano M, Sagami Y, Endo Y, Utsumi A, et al. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome. J Gastroenterol 2002, 37(suppl 14):145-150.
4. Selye H A syndrome produced by diverse nocuous agents. Nature 1936, 138:32.
5. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984, 295:13-25.
6. Iversen S, Kupfermann I, Kandel ER Emotional states and feelings. Principles of Neural Science 2000, 982-997. McGraw-Hill, New York. 4th ed. E.R. Kandel, J.H. Schwartz, T.M. Jessel (Eds.).
7. Molitch ME. Neuroendocrinology and the neuroendocrine system. In; Goldman L, Bennett JC, edt., Drazen JM, Gill GN, Griggs RC, Kokko JP, Manell GL, Powell DW, Schaffer AI, consult edt., Cecil Text Book of Medicine, WB Saunders, Philadelphia, pp. 1198-1207, 2000.
8. Vale W, Spiess J, Rivier C, Rivier J Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and b-endorphin. Science 1981, 213:1394-1397.
9. Petrusz P, Merchenthaler I The corticotropin-releasing factor system. Neuroendocrinology 1992, 129-183. CRC, Boca Raton. C.B. Nemeroff (Ed.).
10. Dunn AJ, Berridge CW Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Rev 1990, 15:71-100.
11. Lovejoy DA, Balment RJ Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen Comp Endocrinol 1999, 115:1-22.
12. Hauger RL, Grigoriadis DE, Dallman ME, Plotsky PM, Vale WW, Dautzenberg FM International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 2003, 55:21-26.
13. Zoumakis E, Kalantaridou SN, Makrigiannakis A CRH-like peptides in human reproduction. Curr Med Chem 2009, 16:4230-4235.
14. Arbiser JL, Morton CC, Bruns GA, Majzoub JA Human corticotropin releasing hormone gene is located on the long arm of chromosome 8. Cytogenet Cell Genet 1988, 47:113-116.
15. Liu Y, Kamitakahara A, Kim AJ, Aguilera G Cyclic adenosine 3',5'-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology 2008, 149:3512-3520.
16. Majzoub JA Corticotropin-releasing hormone physiology. Eur J Endocrinol 2006, 155:S71-S76.
17. Owens MJ, Nemeroff CB Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991, 43:425-473.
18. Lenz HJ, Raedler A, Greten H, Vale WW, Rivier JE Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous cortocotropin-releasing factor. Gastroenterology 1988, 95:1510-1517.
19. Gue M, Junien JL, Bueno L Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology 1991, 100:964-970.
20. Monnikes H, Schmidt BG, Taché Y Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 1993, 104:716-723.
21. Williams CL, Peterson JM, Villar RG, Burks TF Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987, 253:G582-G586.
22. Castro M, Elias LL, Elias PCL, Moreira C Physiology and pathphysiology of the HPA axis. Cushing's Syndrome: Pathphysiology, Diagnosis, and Treatment 2011, 1-20. Humana Press, Sao Paulo. M.D. Bronstein (Ed.).
23. Plotsky PM Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol 1991, 3:1-9.
24. Makrigiannakis A, Margioris AN, Zoumakis E, Stournaras C, Gravanis A The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinol-ogy 1999, 70:451-459.
25. Taché Y, Million M Central corticotropin-releasing factor and the hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. Physiology of the Gastrointestinal Tract 2006, 791-816. Academic Press. 4th ed. L.R. Johnson (Ed.).
26. Liu S, Ren W, Qu MH, Bishop GA, Wang GD, Wang XY, et al. Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br J Pharmacol 2010, 159:222-236.
27. Campbell EA, Linton EA, Wolfe CD, Scraggs PR, Jones MT, Lowry PJ Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987, 64:1054-1059.
28. Molitch ME Anterior pituitary. Cecil Text Book of Medicine 2000, 1208-1250. WB Saunders, Philadelphia. L. Goldman, J.C. Bennett, J.M. Drazen, G.N. Gill, R.C. Griggs, J.P. Kokko, G.L. Manell, D.W. Powell, A.E. Schaffer (Eds.).
29. Chen R, Lewis K, Perrin M, Vale W Expression cloning of a human corticotropin-releasing factor receptor. PNAS 1993, 90:8967-8971.
30. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. PNAS 1995, 92:2969-2973.
31. Primus RJ, Yevich E, Baltazar C, et al. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 1997, 17:308-316.
32. Pett KV, Viau V, Bittencourt JC, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428:191-212.
33. Timpl P, Spanagel R, Sillaber I, et al. Impaired stress response and anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998, 19:162-166.
34. Elenkov IJ, Webster EL, Torpy DJ, et al. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann NY Acad Sci 1999, 876:1-11.
35. Mönnikes H, Schmidt BG, Raybould HE, et al. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am J Physiol 1992, 262:G137-G143.
36. Müller M, Preil J, Renner U, et al. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal grand: implications for HPA system regulation. Endocrinology 2001, 142:4150-4153.
37. Sajdyk TJ, Gehlert DR Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Res 2000, 877:226-234.
38. Roozendaal B, Brunson KL, Holloway BL, et al. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 2002, 99:13908-13913.
39. McNally GP, Akil H Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 2002, 112:605-617.
40. Bakshi VP, Smith-Roe S, Newman SM, et al. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J Neurosci 2002, 22:2926-2935.
41. Radulovic J, Ruhmann A, Liepold T, et al. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 1999, 19:5016-5025.
42. Swiergiel AH, Takahashi LK, Rubin WW, et al. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res 1992, 587:263-268.
43. Coste SC, Kesterson RA, Heldwein KA, et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000, 24:403-409.
44. Bale TL, Giordano FJ, Hickey RP, et al. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 2002, 99:7734-7739.
45. Emanuel RL, Torday JS, Asokananthan N, et al. Direct effects of corticotropin-releasing hormone on fetal lung explants. Peptides 2000, 21:1819-1829.
46. Radulovic M, Dautzenberg F, Sydow S, et al. Corticotropine-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J Immunol 1999, 162:3013-3021.
47. Baigent SM, Lowry PJ mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol 2000, 25:43-52.
48. Hsu SY, Hsueh AJ Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 2001, 7:605-611.
49. Maillot C, Million M, Wei JY, et al. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 2000, 119:1569-1579.
50. Iwakiri Y, Chijiiwa Y, Motomura Y, et al. Presence of functional receptors for corticotropin releasing hormone in caecal circular smooth muscle cells of guinea pig. Life Sci 1997, 60:857-864.
51. Lovenberg TW, Chalmers DT, Liu C, et al. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995, 136:4139-4142.
52. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, et al. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 2000, 21:1799-1809.
53. Dautzenberg FM, Higelin J, Teichert U Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. Eur J Pharmacol 2000, 390:51-59.
54. Slominski A, Wortsman J, Luger T, et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000, 80:979-1020.
55. Palchaudhuri MR, Wille S, Mevenkamp G, et al. Corticotropin-releasing factor type 1 from Tupaia belangeri Cloning, functional expression and tissue distribution. Eur J Biochem 1998, 258:78-84.
56. Muramatsu Y, Sugino N, Suzuki T, et al. Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab 2001, 86:1362-1369.
57. Grammatopoulos D, Dai Y, Chen J, et al. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol 1998, 138:185-198.
58. Grammatopoulos DK, Hillhouse EW Role of corticotropin-releasing hormone in onset of labour. Lancet 1999, 354:1546-1549.
59. Kageyama K, Suda T Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocr J 2009, 56:335-344.
60. Behan DE, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 1995, 16:362-382.
61. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 1991, 349:423-426.
62. Henry BA, Lightman SL, Lowry CA Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1-and vimentin-immunoreactive fibres. J Neuroendocrinol 2005, 17:135-144.
63. Karolyi IJ, Burrows HL, Ramesh TM, Nakajima M, Lesh JS, Seong E, et al. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci USA 1999, 96:11595-11600.
64. Loriaux DL The adrenal cortex. Cecil Text Book of Medicine 2000, 1250-1257. WB Saunders, Philadelphia, consult edt. L. Goldman, J.C. Bennett, J.M. Drazen, G.N. Gill, R.C. Griggs, J.P. Kokko, G.L. Manell, D.W. Powell, A.I. Schaffer (Eds.).
65. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988, 239:766-768.
66. Hackman DA, Farah MJ, Meaney MJ Socioeconomic status and the brain: mechanistic insights from human and animal research. Nat Rev Neurosci 2010, 11:651-659.
67. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
68. Saito YA, Schoenfeld P, Lockex GRI The epidemiology of irritable bowel syndrome in North America (a systemic review). Am J Gastroenterol 2002, 97:1910-1915.
69. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000, 119:654-660.
70. Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V, et al. Irritable bowel syndrome, health care use, and costs (a U.S. managed care perspective). Am J Gastroenterol 2003, 98:600-607.
71. Fukudo S, Nomura T, Muranaka M, Taguchi F Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 1993, 17:133-141.
72. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992, 33:825-830.
73. Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990, 113:828-833.
74. Fukudo S, Suzuki J Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987, 151:373-386.
75. Welgan P, Meshkinpour H, Beeler M Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988, 94:1150-1156.
76. Kanazawa M, Palsson OS, Thiwan SIM, Turner MJ, van Tilburg MAL, Gangarosa LM, et al. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 2008, 103:2550-2561.
77. Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S Corticotropin-releasing hormone receptor-1 antagonist blocks braoin-gut activation induced by colonic distention in rats. Gastroenterology 2005, 129:1533-1543.
78. Taché Y, Mönnikes H, Rivier J, et al. Role of CRF in stress-related alterlations of gastric and colonic motor function. Ann N Y Acad Sci 1993, 697:233-243.
79. Taché Y, Perdue MH Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004, 16(suppl 1):137-142.
80. Miyata K, Ito H, Fukudo S Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 1998, 274:G827-G831.
81. Gulpinar MA, Bozkurt A, Coskun T, et al. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats. Am J Physiol 2000, 278:G924-G929.
82. Bonaz B, Taché Y Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal pellet output: role of corticotropin-releasing factor. Brain Res 1994, 641:21-28.
83. Martinez V, Rivier J, Wang L, et al. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF-and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther 1997, 280:754-760.
84. Million M, Wang L, Martinez V, et al. Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats. Brain Res 2000, 877:345-353.
85. Fargeas MJ, Fioramonti J, Bueno L Central action of interleukin 1 beta on intestinal motility in rats: mediation by two mechanisms. Gastroenterology 1993, 104:377-383.
86. Monnikes H, Tebbe J, Bauer C, et al. Neuropeptide Y in the paraventricular nucleus of the hypothalamus stimulates colonic transit by peripheral cholinergic and central CRF pathways. Neurogastroenterol Motil 2000, 12:343-352.
87. Million M, Maillotx C, Saundersx P, et al. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Am J Physiol 2002, 282:G34-G40.
88. Martinez V, Wang L, Rivier J, Grigoriadis D, Tach6 Y Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physio1 2004, 556:221-234.
89. Martínez V, Taché Y Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Res 2001, 893:29-35.
90. Million M, Grigoriadis DE, Sullivan S, Crowe PD, McRoberts JE, Zhou CY, et al. A novel watersoluble selective CRF1 receptor antagonist, NBI 35965, blunts stressinduced visceral hyperalgesia and colonic motor function in rats. Brain Res 2003, 985:32-42.
91. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A 2000, 97:6079-6084.
92. Lu L, Liu D, Ceng X, Ma L Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 2000, 12:4398-4404.
93. Funada M, Hara C, Wada K Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur J Pharmaco1 2001, 430:77-281.
94. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 2002, 22:193-199.
95. Taché Y, Martinez V, Million M, Rivier J Corticotropin-releasing factor and the brain-gut motor response to stress. Can J Gastroenterol 1999, 13(suppl A):18A-25A.
96. Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, et al. Stress-induced behavior require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA 1999, 96:8283-8288.
97. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
98. Elam M, Thorén P, Svensson TH Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res 1986, 375:117-125.
99. Lechner SM, Curtis AL, Brons R, Valentino RJ Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997, 756:114-124.
100. Kiss A, Palkovits M, Aguilera G Neural regulation of corticotropin releasing hormone (CRH) and CRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat. J Neuroendocrinol 1996, 8:103-112.
101. Saito K, Kanazawa M, Fukudo S Colorectal distention induces hippocampal noradrenalinee release in rats. Brain Res 2002, 947:146-149.
102. Schulz DW, Mansbach RS, Sprous J, Braselton JP, Collins J, Corman M, et al. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 1996, 93:10477-10482.
103. Mönnikes H, Schmidt BG, Tebbe J, Bauer C, Taché Y Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus stimulates colonic motor function in rats. Brain Res 1994, 644:101-108.
104. Valentino RJ, Foote SL, Aston-Jones G Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983, 270:363-367.
105. Mönnikes H, Raybould HE, Schmidt BG, Taché Y CRF in the paraventricular nucleus of hypothalamus stimulates colonic motor activity in fasted rats. Peptides 1993, 14:743-747.
106. Traub RJ, Silva E, Gebhart GF, Solodkin A Noxious colorectal distention induced-c-Fos protein in limbic brain structures in the rat. Neurosci Lett 1996, 215:165-168.
107. Fukudo S, Nomura T, Hongo M Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998, 428:45-49.
108. Mayer EA, Sytnik B, Reddy SN, et al. Corticotropin-releasing factor (CRF) increases post-prandial duodenal motor activity in humans. Neurogastroenterol Motil 1992, 4:53-60.
109. Dinan TG, Quigley EM, Ahmed SM, Scully P, OBrien S, OMahony L, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
110. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009, 21:149-159.
111. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009, 137:1954-1962.
112. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, et al. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?. Am J Physiol Gastrointest Liver Physiol 2009, 296:G1299-G1306.
113. Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety 2010, 27:417-425.
114. Sahay A, Hen R Adult hippocampal neurogenesis in depression. Nat Neurosci 2007, 10:1110-1115.
115. Bayatti N, Behl C The neuroprotective actions of corticotropin releasing hormone. Ageing Res Rev 2005, 4:258-270.
116. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004, 53:958-964.
117. Tayama J, Sagami Y, Shimada Y, Hongo M, Fukudo S Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol Motil 2007, 19:471-483.
118. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ Read NW.Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996, 347:150-153.
119. Collins SM, McHugh K, Jacobson K, Khan I, Riddell R, Murase K, et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996, 111:1509-1515.
120. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122:1778-1783.
121. Spiller R, Garsed K Postinfectious irritable bowel syndrome. Gastroenterology 2009, 136:1979-1988.
122. Weston AP, Biddle WL, Bhatia PS, Miner PB Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
123. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132:26-37.
124. Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009, 137:1425-1434.
125. Wood JD, Alpers DH, Andrews PL Fundamentals of neurogastroenterology. Gut 1999, 45(suppl 2):II6-II16.
126. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997, 9:271-279.
127. Santos J, Saunders PR, Hanssen NP, Yang PC, Yates D, Groot JA, et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999, 277(2 Pt 1):G391-G399.
128. Barreau F, Cartier C, Leveque M, Ferrier L, Moriez R, Laroute V, et al. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J Physiol 2007, 580(Pt 1):347-356.
129. Wallon C, Yang PC, Keita AV, Ericson AC, McKay DM, Sherman PM, et al. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 2008, 57:50-58.
130. Wallon C, Söderholm JD Corticotropin-releasing hormone and mast cells in the regulation of mucosal barrier function in the human colon. Ann N Y Acad Sci 2009, 165:206-210.
131. Liu S, Gao X, Gao N, Wang X, Fang X, Hu HZ, et al. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. J Comp Neurol 2005, 481:284-298.
132. Saito-Nakaya K, Hasegawa R, Nagura Y, Ito H, Fukudo S Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil 2008, 20:1147-1156.
133. Fukudo S, Saito K, Sagami Y, Kanazawa M Can modulating corticotropin releasing hormone receptors alter visceral sensitivity?. Gut 2006, 55:146-148.
134. Fukudo S Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol 2007, 42(suppl 17):48-51.
135. Hsu SY, Hsueh AJ Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 2001, 7:605-611.
136. Million M, Wang L, Wang Y, Adelson DW, Yuan PQ, Maillot C, et al. CRF2 receptor activation prevents colorectal distension-induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 2005, 55:172-181.